ImmunoGen's antibody humanization technology reported to be superior to conventional methods Oct. 25, 1996
Cell motility factor with potential in cancer diagnostics and therapeutics available for licensing Oct. 25, 1996
Licensees sought for antibodies specific for P31 antigen for use in lung cancer detection Oct. 25, 1996
IRS-2 polypeptide for diagnosis of insulin- or immune-related disorders available for licensing Oct. 25, 1996
RSS